Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading
Neumora Therapeutics, Inc. saw a −80.75% drop in its stock price, which is now 2.04 USD. The company has a market cap of 1.71 billion USD.
Stay updated with the latest news and articles about BioNexus Gene Lab Corp.
Neumora Therapeutics, Inc. saw a −80.75% drop in its stock price, which is now 2.04 USD. The company has a market cap of 1.71 billion USD.
Senti Biosciences, Inc. saw a significant increase of +428.24%, with its stock price reaching 11.41 USD and a market cap of 105.38 M USD.